Report Overview

The global microarray analysis market was pegged at US$ 4.79 billion in 2021 and is expected to witness a CAGR of 7.6% during the forecast period.

Market Fundamentals

Microarray is a technology for analysis of gene expression or for gene mapping. Thousands of gene sequences are placed on a glass slide called a gene chip; the sample containing DNA or RNA is placed in contact with the gene chip. When the sample and the gene sequences on the chip base pair, they produce light which is further measured and used to identify genes that are expressed in the sample. DNA microarray technology enables researchers to study, better understand and address issues which were once non-traceable. There are many applications of microarray analysis including gene discovery, disease diagnostics, drug discovery as well as toxicological research.

[654533434]

Market Dynamics                      

Rising incidence of diseases such as cancer, growing application of microarray analysis in disease diagnosis & prognosis, and the rising funding for genomic research are some of the major factors expected to fuel the market growth. Moreover, research institutes and companies are entering into strategic collaborations for conducting R&D activities and this factor is also playing a pivotal role in propelling the global microarray analysis market growth. However, advancements in NGS technology have led to its growing adoption and this is hindering the growth of microarray analysis market to a certain extent.

Market Ecosystem

The global microarray analysis market has been analyzed from five perspectives: products & services, type, application, end user, and region. 

Microarray Analysis Market by Products & Services

[2343343]

Based on products & services, the global microarray analysis market has been segmented into instruments, consumables, and software & services. Consumables segment held the largest share of the global microarray analysis market. The rising number of research & development activities has led to high demand and regular bulk purchase of consumables such as reagents, buffers, and primers and is one of the major factors responsible for the large share of this segment. 

Microarray Analysis Market by Type

Based on type, the global microarray analysis market has been segmented into DNA microarrays, protein microarrays, and others. DNA microarrays segment accounted for the largest share of the microarray analysis market. The major factors attributing to the dominance of this segment include the growing applications of DNA microarray in the genomics research, identifying drug-candidates, somatic mutations in cancers as well as understanding the molecular biology of disease that helps in disease diagnosis. Moreover, increasing use of the DNA microarray analysis in toxicogenomic studies is also propelling the growth of the DNA microarrays market. 

Microarray Analysis Market by Application

Based on application, the global microarray analysis market has been segmented into research, diagnostics, drug discovery, and other applications. Research applications dominated the global market during forecast period. The rising public-private funding for conducting various research studies in the field of genomics, proteomics, cancer diagnostics, and drug development is one of the major drivers of this market segment. 

Microarray Analysis Market by End User

Based on end user, the market has been segmented into pharmaceutical & biotechnology companies, diagnostic laboratories, research & academic institutes, and other end users. Research & academic institutes held the largest market share of the global microarray analysis market owing to the increasing use of microarray technology in various research studies and the greater influx of funding to these institutes.

Microarray Analysis Market by Region

Regionally, the global microarray analysis market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America dominated the global market for microarray analysis holding the largest revenue share. The major factors driving the growth of microarray analysis market in this region include the greater private-public funds for research studies and high usage of microarray technology for various genomic and proteomic research. Moreover, large number of research institutes and the presence of the leading microarray manufacturers are also propelling the microarray analysis market growth in this region. For instance, The National Institute of Cancer received approximately US$ 42.1 million in cancer research funding in 2019. Microarrays are used to identify cancer cells and to determine the genetic structure of the cell. Furthermore, the increased demand for new drugs has resulted in increased funding for proteomics and genomics, which has contributed to the growth of the microarray analysis market.

Competitive Landscape

Some of the prominent players operating in the global microarray analysis market include 

• Thermo Fisher Scientific Inc. 
• Illumina, Inc.
• PerkinElmer Inc. 
• Agilent Technologies, Inc.
• Arrayit Corporation
• Bio-Rad Laboratories, Inc.
• Microarrays Inc.
• Merck KGaA.
• Qiagen N.V.
• Danaher Corporation

Strategic Developments

• In October 2020, PathogenDx, Inc. received an AOAC Performance Tested Methods SM (PTM) Certificate from the AOAC Research Institute for their EnviroX-f, an ultra-rapid microarray test that is designed for food safety.
• In December 2020, Agilent Technologies Inc. received clearance from the Ministry of Health, Labour and Welfare (MHLW) in Japan for the GenetiSure Dx Postnatal Assay, a microarray-based assay for diagnostic use.
• In March 2021, Oxford BioDynamics Plc signed a supply and resale agreement with Agilent Technologies for the manufacture and sale of the new EpiSwitch Explorer Array Kit, a commercial microarray kit for high-resolution 3D genome profiling and biomarker discovery is now available.
• In April 2021, PathogenDx, Inc., received the U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for its patented COVID-19 multiplexed viral diagnostic assay, DetectXRv. DetectXRv is a RT-PCR and DNA microarray hybridization test intended for the qualitative detection of nucleic acids from SARS-CoV-2.

Frequently Asked Questions About This Report